Summary & Overview
HCPCS Level II J0911: Taurolidine-Heparin Catheter Lock for Hemodialysis
HCPCS Level II code J0911 represents the instillation of taurolidine 1.35 mg combined with heparin sodium 100 units used as a central venous catheter lock for adult patients receiving chronic hemodialysis. This code identifies a specialized vascular access maintenance procedure that supports catheter patency and infection prevention, making it relevant to dialysis providers, outpatient infusion centers, and payers managing chronic renal replacement therapy populations nationwide. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and service setting, benchmarking considerations for reimbursement and utilization, common billing modifiers and coding practice notes, and relevant payer policy highlights where available. The publication also outlines documentation elements and potential audit focal points for claims involving catheter lock solutions. Data not available in the input is noted where applicable; this summary focuses on nationally applicable implications rather than state-specific rules.
Billing Code Overview
HCPCS Level II code J0911 describes the instillation of taurolidine 1.35 mg and heparin sodium 100 units as a central venous catheter lock intended for adult patients receiving chronic hemodialysis. The service type is a catheter lock instillation used to maintain catheter patency and reduce infection risk in long-term hemodialysis access. The typical site of service is an outpatient dialysis center or other ambulatory setting where chronic hemodialysis is administered.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with end-stage renal disease (ESRD) receiving chronic hemodialysis presents to the outpatient dialysis center for a scheduled hemodialysis session. The patient has a tunneled central venous dialysis catheter that is routinely locked between treatments to maintain catheter patency and reduce the risk of catheter-related bloodstream infection. Prior to connecting the dialysis circuit, the dialysis nurse aspirates residual lock solution, inspects the catheter exit site, performs standard line disinfection, and then instills a catheter lock consisting of taurolidine 1.35 mg combined with heparin sodium 100 units into each lumen according to facility protocol. Documentation includes catheter type, volumes instilled, lot numbers for drugs used, patient tolerance, and the clinical indication for catheter lock therapy (chronic hemodialysis via central venous catheter). Typical site of service is an outpatient dialysis center or hospital-based dialysis unit. Service type is a medication instillation/catheter lock performed as part of routine maintenance of a central venous dialysis catheter for adult chronic hemodialysis patients.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier. | Use when no special reporting modifier applies. |